Edema macula. Other specified disorders of eye and adnexa in diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: 16 diabetic patients with elevated double-walled macular thickness in one eye randomly selected in addition to intravascular injection of Avastin at baseline and 1
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 62 Years
Inclusion criteria
Inclusion criteria: Diabetic patients with retinopathy who have macular edema due to increased macular thickness or vision loss are indicative of anti-VEGF treatment. A transparent mediator for a thorough examination Visual activity of both eyes are better than 1/10 and less than 4/10 Patient consent to Participate in the Study The thickness of the central area of the macula at the start of treatment is greater than 300 microns
Exclusion criteria
Exclusion criteria: History of bone surgery The presence of atrophy, scarring, fibrosis and hard exudates in the macular center that affects visual acuity. Uncontrolled blood pressure Presence of active eye infectious disease There are other complications of diabetes in the eyes, which leads to an increase in the thickness of the macula. The presence of other synchronous eye pathologies such as glaucoma and cataracts.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual activity. Timepoint: Before and two months after the intervention. Method of measurement: Examination by ophthalmologist.;Foie thickness. Timepoint: Before and two months after the intervention. Method of measurement: Optical Coherence Topography and Examination by ophthalmologist.;Macular volume. Timepoint: Before and two months after the intervention. Method of measurement: Optical Coherence Topography and Examination by ophthalmologist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohsen Pourazizi
Esfahan University of Medical Sciences
Outcome results
None listed